Riskpilot← Back to searchSign inGet full accessKIPERVIKA LEGESENTER AS
ASActiveOrg 983607888Keiser Willhelmsgate 24, 6002 ÅlesundGeneral medical practice activities · NACE 8621Est. 20019 employees
Revenue 2024
NOK 4,3M
+19% vs 2023
EBITDA margin
1.7%
-35% vs 2023
Equity ratio
76.8%
Financial strength
Net profit 2024
NOK 51K
+6% vs 2023
| Revenue | NOK 4,3M | +19% |
| EBITDA | NOK 73K | -35% |
| Net profit | NOK 51K | +6% |
| Total assets | NOK 1,8M | +2% |
| Equity | NOK 1,4M | +4% |
| Employees | 9 | — |
Legal name
KIPERVIKA LEGESENTER AS
Org number
983607888
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. september 2001
Share capital
NOK 104 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder.
Company purpose
Administrasjon av helsetjenester og andre tjenester som herved naturlig står i forbindelse, samt deltakelse ved aksjeinnskudd eller på annen måte i selskap med økonomisk formål.
Address
Keiser Willhelmsgate 24, 6002 Ålesund
Phone
+4770104650
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 403 | 3 791 | 3 962 | 3 641 | 4 329 |
| Staff expenses | −1 540 | −1 799 | −1 865 | −1 678 | −1 837 |
| EBITDA | 161 | 180 | 261 | 113 | 73 |
| Depreciation & amort. | −50 | −75 | −55 | −30 | −14 |
| EBIT | 111 | 105 | 206 | 83 | 60 |
| Net financials | −0 | −0 | −0 | −1 | 0 |
| Profit before tax | 111 | 105 | 206 | 83 | 60 |
| Tax | 24 | 23 | 45 | 35 | 9 |
| Net profit | 86 | 82 | 161 | 48 | 51 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 398 | 1 491 | 1 751 | 1 724 | 1 761 |
| Equity | 1 011 | 1 094 | 1 254 | 1 302 | 1 352 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 387 | 397 | 497 | 422 | 409 |
| Total debt | 387 | 397 | 497 | 422 | 409 |
EBITDA margin
1.7%
This company
15.8%
Market median
-89% vs market
20202024
Equity ratio
76.8%
This company
38.2%
Market median
+101% vs market
20202024
Return on equity
3.7%
This company
18.4%
Market median
-80% vs market
20202024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20202024
Asset turnover
2.46×
This company
1.12×
Market median
+120% vs market
20202024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2019 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KIPERVIKA LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Enersen | Board of Directors | 0 companies |
| Kristoffer Sandnes | Board of Directors | 0 companies |
| John Duaas Wilhelmsen | Chairman | 0 companies |
| Helge André Langnes | Board of Directors | 0 companies |
| Liv Rønneberg | Board of Directors | 0 companies |